Elevation Oncology, Inc. Contracts & Agreements

30 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Change in Control and Severance Agreement
Change of Control Agreements
Elevation Oncology, Inc.
2024
Warrant to Purchase Common Stock, issued March 1, 2024, to K2 HealthVentures Equity Trust LLC
Warrant Agreements
Elevation Oncology, Inc.
2024
First Amendment to Loan and Security Agreement, dated March 1, 2024, by and among the Company, the lenders, and K2 HealthVentures LLC, as administrative agent
Loan Agreements
Elevation Oncology, Inc.
2024
Employment Agreement dated July 12, 2023 by and between the Registrant and Joseph J. Ferra, Jr
Employment Agreements
Elevation Oncology, Inc.
2023
Employment Agreement dated July 12, 2023 by and between the Registrant and Tammy Furlong
Employment Agreements
Elevation Oncology, Inc.
2023
Underwriting Agreement dated June 8, 2023
Underwriting Agreements
Elevation Oncology, Inc.
2023
Form of Purchase Warrant
Warrant Agreements
Elevation Oncology, Inc.
2023
Form of Pre-Funded Warrant
Warrant Agreements
Elevation Oncology, Inc.
2023
Separation Agreement, dated January 5, 2023, between the Company and Shawn M. Leland
Separation Agreements
Elevation Oncology, Inc.
2023
Offer Letter dated March 16, 2022, by and between the Registrant and David Dornan
Elevation Oncology, Inc.
Biotechnology
2023
Warrant to Purchase Common Stock, issued July 27, 2022 to K2 HealthVentures Equity Trust LLC
Warrant Agreements
Elevation Oncology, Inc.
2022
Loan and Security Agreement, dated July 27, 2022, by and among the Company, the lenders, K2 HealthVentures LLC, as administrative agent, and Ankura Trust Company, LLC, as...
Loan Agreements
Elevation Oncology, Inc.
2022
License Agreement, dated July 27, 2022, by and between the Company and CSPC Megalith Biopharmaceutical Co., Ltd
License Agreements
Elevation Oncology, Inc.
Biotechnology
DE
2022
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Elevation Oncology, Inc.
Biotechnology
2022
Employment Agreement dated February 2, 2021 by and between Elevation Oncology, Inc. and Valerie Malyvanh Jansen, as amended
Employment Agreements
Elevation Oncology, Inc.
Biotechnology
2022
Collaboration Agreement dated June 14, 2021, between Caris MPI, Inc. and Elevation Oncology, Inc
Collaboration Agreements
Elevation Oncology, Inc.
Biotechnology
NY
2021
Form of Underwriting Agreement
Underwriting Agreements
Elevation Oncology, Inc.
Biotechnology
NY
2021
Form of Common Stock Certificate
Stock Agreements
Elevation Oncology, Inc.
Biotechnology
2021
Form of Indemnity Agreement
Elevation Oncology, Inc.
2021
2021 Equity Incentive Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements
Bonus & Incentive Agreements
Elevation Oncology, Inc.
Biotechnology
DE
2021
2021 Employee Stock Purchase Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements
Stock Agreements
Elevation Oncology, Inc.
Biotechnology
DE
2021
Employment Agreement dated July 12, 2019 by and between Elevation Oncology, Inc. and Shawn Leland, as amended
Employment Agreements
Elevation Oncology, Inc.
Biotechnology
DE
2021
Employment Agreement dated June 6, 2021 by and between Elevation Oncology, Inc. and Joseph J. Ferra, Jr
Employment Agreements
Elevation Oncology, Inc.
2021
Collaboration Agreement dated June 14, 2021, between Caris MPI, Inc. and Elevation Oncology, Inc
Collaboration Agreements
Elevation Oncology, Inc.
2021
Amended and Restated Investors Rights Agreement, dated November 10, 2020 by and among Elevation Oncology, Inc. and certain of its stockholders
Investor Rights Agreements
Elevation Oncology, Inc.
2021
2019 Equity Incentive Plan, as amended, and forms of award agreements
Bonus & Incentive Agreements
Elevation Oncology, Inc.
Biotechnology
CA
2021
Asset Purchase Agreement dated May 28, 2019, by and between the Registrant and Merrimack Pharmaceuticals, Inc., as amended
Purchase Agreements
Elevation Oncology, Inc.
Biotechnology
DE
2021
Amended and Restated Collaboration Agreement dated January 24, 2007 between Dyax Corp. and Merrimack Pharmaceuticals, Inc., as amended
Collaboration Agreements
Elevation Oncology, Inc.
2021
Commercial License Agreement dated June 4, 2008 between Selexis SA and Merrimack Pharmaceuticals, Inc
License Agreements
Elevation Oncology, Inc.
2021
Form of IPO Participation Right Letter
Participation Agreements
Elevation Oncology, Inc.
Biotechnology
2021